Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Medela Potentia TbkISX:MDLA +0.96%13 EV-to-EBIT is 4.58 as of Sep. 05, 2026, which is 5% below its 10-year median of 4.80. GuruFocus rates ISX:MDLA with a GF Score™ of 13/100. The stock has 2 warning signs investors should review. Among 96 Medical Distribution companies, PT Medela Potentia Tbk ranks better than 89.58% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
PT Medela Potentia Tbk's Enterprise Value for the quarter that ended in Jun. 2026 was Rp2,421,342 Mil.
PT Medela Potentia Tbk's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp553,428 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, PT Medela Potentia Tbk's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Medela Potentia Tbk EV-to-EBIT vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Medela Potentia Tbk's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where PT Medela Potentia Tbk's EV-to-EBIT falls into.
PT Medela Potentia Tbk's current Enterprise Value is Rp2,533,444 Mil.
PT Medela Potentia Tbk's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp553,428 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Medela Potentia Tbk (ISX:MDLA) has a EV-to-EBIT of 4.58 as of Sep. 05, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on PT Medela Potentia Tbk and its competitors. This is near median its historical median of 4.80. Over the past decade, PT Medela Potentia Tbk's EV-to-EBIT has ranged from 3.62 to 6.05. According to the industry distribution chart, PT Medela Potentia Tbk ranks #10 out of 96 companies in the Medical Distribution industry, placing it in the top 10.4%.
Is PT Medela Potentia Tbk's EV-to-EBIT too high?
PT Medela Potentia Tbk's current EV-to-EBIT of 4.58 is near median its 10-year median of 4.80. Over the past 10 years, this metric has ranged from a low of 3.62 to a high of 6.05. The Medical Distribution industry median EV-to-EBIT is 11.20. PT Medela Potentia Tbk's value of 4.58 is 59.1% below this industry median. Based on the distribution chart, PT Medela Potentia Tbk ranks #10 out of 96 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, PT Medela Potentia Tbk has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does PT Medela Potentia Tbk's EV-to-EBIT compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Medela Potentia Tbk ranks #10 out of 96 companies for EV-to-EBIT. This places PT Medela Potentia Tbk in the top 10% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 11.20. PT Medela Potentia Tbk's value of 4.58 is 59.1% below this benchmark. Historically, PT Medela Potentia Tbk's own EV-to-EBIT has ranged from 3.62 to 6.05 over the past decade. While the company's 10-year median is 4.80 vs. the industry median of 11.20, PT Medela Potentia Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Distribution company?
The median EV-to-EBIT among Medical Distribution companies is 11.20, based on 96 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Medela Potentia Tbk's current EV-to-EBIT of 4.58 is 59.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on PT Medela Potentia Tbk and its competitors. For the Medical Distribution industry, the median EV-to-EBIT is 11.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Medela Potentia Tbk's current EV-to-EBIT is 4.58, which is near median its own 10-year median of 4.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medela Potentia Tbk stock overvalued right now?
PT Medela Potentia Tbk (ISX:MDLA) has a current EV-to-EBIT of 4.58. The current EV-to-EBIT is 4.58, which is near median its 10-year median of 4.80 and 59.1% below the Medical Distribution industry median of 11.20. PT Medela Potentia Tbk's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For PT Medela Potentia Tbk (ISX:MDLA), the current EV-to-EBIT is 4.58 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Medela Potentia Tbk is a healthcare-focused holding company engaged in pharmaceutical distribution, medical device manufacturing, and marketing services. It is engaged in the distribution and marketing of pharmaceutical products, health products, and medical devices. It also manufactures medical devices and implements web portals and digital platforms for commercial purposes through its subsidiaries. The Company manages three main operating segments, namely pharmaceutical products, healthcare products, and medical devices.
13GF Score
Get the complete analysis for ISX:MDLA
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:MDLA has been successfully added to your 
